Fundz
Back to SEC Filings
10-QMEDIUM RiskDETERIORATING

BOSTON SCIENTIFIC CORP

www.bostonscientific.com
Filed: Nov 2, 2026 CIK: 0000885725Health Care
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

Boston Scientific's Q3 2026 results were materially impacted by a cybersecurity incident identified on August 25, 2026, which disrupted manufacturing and order fulfillment, causing Q3 net income to fall 22.9% year-over-year despite modest net sales growth of 1.5%. While nine-month results show stronger growth (6.7% net sales, 27.1% net income) aided by a discrete tax benefit, the company faces compounding headwinds including increased Electrophysiology competition, LAAC/WATCHMAN market deceleration, higher litigation charges, and ongoing ERP implementation risks.

Red Flags Detected (9)

Material cybersecurity incident (Aug 25, 2026) disrupted manufacturing, order processing, and shipping, directly impacting Q3 financial results

Cash and cash equivalents dropped sharply from $1,965M to $609M (69% decline) from Dec 2025 to Sep 2026

Q3 net income attributable to shareholders fell 22.9% YoY ($755M to $582M)

6 more red flags detected

Key Takeaways

Q3 2026 profitability significantly impaired by one-time cybersecurity disruption despite revenue growth

Nine-month performance remains solid, aided by a one-time tax benefit, masking underlying Q3 weakness

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateNov 2, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence78%
Red Flags9

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings